




Poliomyelitis, or polio as it is commonly known, is a disease caused by an enterovirus found
throughout the world. Although it is often associated with paralysis of one or more limbs, it is
more common for children to experience asymptomatic cases of the disease, which convey life-
long immunity. While lameness associated with polio has long been known in Nigeria, during the
colonial period immunization efforts focused mainly on expatriates. Later, with the implementa-
tion of the Expanded Programme on Immunisation during the 1980s, polio vaccination was
included as part of primary health care. However, it was only after the 1988 World Health
Assembly vote to eradicate polio worldwide that intensive efforts to vaccinate all children under
five for polio began. Initial efforts, which focused only on polio vaccination, may be characterized
as an ‘‘override approach.’’ In 2006, Nigeria had the greatest number of confirmed cases of polio
worldwide. However, with the implementation of a more ‘‘collaborative approach,’’ incorporating
other vaccines and health incentives such as bed nets, the number of polio cases declined. By the
end of 2010, case numbers had declined dramatically and these numbers remain low, reflecting
government, NGO, and community efforts to work together to end polio transmission in
Nigeria.
The focus on polio in Nigeria over the past two decades reflects member nations’ vote at
the 41st World Health Assembly meeting held in Geneva in 1988 to eradicate the disease
worldwide by 2000.1 Initially implemented in 1995 in Nigeria, the Polio Eradication Ini-
tiative exemplifies what Amartya Sen refers to as an ‘‘override’’ approach.2 By ignoring
local concerns and related national and international issues while assuming that the virtues
of disease eradication—of which there are many—would trump all others, the initiative
foundered. In 2006, the program was revamped to incorporate community health con-
cerns.3 This review considers the historical context and the specific factors which have
led to a dramatic decline in confirmed cases of polio in 2010 (Table 1). While govern-
ment and health officials had hoped that Nigeria would be polio-free by 2011, sixty-two
wild poliovirus cases were confirmed that year, all in northern Nigerian states (Fig. 1).4
This situation suggests that some of the underlying political, social, and economic
problems besetting this global public health campaign persist. Indeed, in 2011 presiden-
tial ⁄gubernatorial elections and subsequent post-election violence, as well as ongoing con-
flict between government officials, state ⁄ federal military police, and members of a
fundamentalist Islamic group in Borno State (in northeastern Nigeria) have hampered,
but not stopped, polio eradication and broader immunization efforts.
Early Documented Experiences of Polio in Nigeria
Polio has long been recognized in Nigeria and has several names which reflect local
understandings of its symptoms or causes—arun aromolapa romolese (literally, disease that
cripples a child’s hands and legs: Yoruba) in the southwest; and örı̈a ngwulö (disease that
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causes paralysis of limbs, lameness; Igbo) in the southeast; and cutar Shan Inna (literally,
disease caused by the drinking of Inna: Hausa) in the north.
In the late 1950s and after Independence, during the early 1960s, researchers began to
study the prevalence of poliomyelitis among Nigerians.5 An increasing incidence of polio
among expatriates during the 1950s led to a growing concern with polio vaccination,
which the introduction of the Salk polio vaccine made possible. This situation developed
as a consequence of the particular epidemiology of the poliovirus. For those who had
Table 1. Cases of Acute Flaccid Paralysis (AFP) and Confirmed Cases of Wild Poliovirus and



















1999 1242 0.5 26 981 98 –
2000 979 0.7 36 638 28 –
2001 1937 3.8 67 56 56 –
2002 3010 5.7 84 202 202 –
2003 3318 6.0 91 355 355 –
2004 4814 8.0 91 782 782 –
2005 4836 6.3 85 831 830 1
2006 5175 6.5 88 1143 1122 21
2007 4277 5.9 94 353 285 68
2008 5536 6.5 93 861 798 63
2009 5501 7.1 95 541 388 153
2010 5996 8.6 95 48 21 27
2011 6099 8.6 94 95 62 33
Source: WHO 2012 http://www.who.int/immunization_monitoring/en/diseases/poliomyelitis/case_count.
cfm.
(accessed 19 April 2012).
Fig. 1. Map of Nigeria, by state with polio distribution, 2011 (UNICEF ⁄ polioinfo website, http://www.polioeradication.
org).
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grown up in hygienic environments where exposure to poliovirus was unlikely, as in
Great Britain during the early 20th century and where prior immunity had not been
obtained, it was possible to contract acute cases of paralytic polio that were life-threaten-
ing, particularly to adolescents and adults since the severity of paralysis increased with
age.6 During the first six months of 1956, ‘‘six adult Europeans’’ contracted polio in
Lagos and at least two expatriates died from polio.7 In July 1956, the Colonial Office
instituted a scheme for vaccinating expatriates working in Nigeria.
At the same time, clinical studies of polio immunity were carried out in Nigeria—in
Lagos (Lagos State), Oloibiri (Niger Delta), and Kadandani (Katsina State; Table 2). In
the 1956 Kadandani study, only 33% of children aged 6-11 months had polio antibodies.8
However by age 10, 100% had polio antibodies, acquiring what is referred to as ‘‘natural
immunity,’’ and hence were immune from the disease. Prior to immunization with the
Salk injectable vaccine and later the Sabin oral vaccine, ‘‘natural immunity’’ was the prin-
ciple means by which Nigerian children were protected from polio.
However, some children did develop polio-related paralysis. Two epidemiological
studies of Nigerian children brought to University College Hospital-Ibadan with paraly-
sis symptoms associated with polio were conducted, the first for the period from 1958
to 1960,9 the second using hospital datafrom 1964 to 1973. Familusi and Adesina found
that polio was prevalent throughout the year in the Ibadan and surrounding areas,
which they attributed to population increase and urban crowding. After a short-lived
polio vaccination program in Ibadan carried out by the World Health Organization in
1974, the number of polio cases declined, leading Familusi and Adesina to advocate for
a regular vaccination program for the disease.10
The Expanded Programme on Immunisation and Polio Vaccination
This advice to vaccinate Nigerian children for polio was not taken up nationally until
1988 when the Nigerian government, with the assistance of UNICEF, implemented the
Expanded Programme on Immunisation, under the leadership of Professor Olikoye Ran-
some-Kuti. The program began with the opening of primary health care centers across
the country.11 According to this global health program, vaccines for six early childhood
diseases—diphtheria, tetanus, whooping cough, measles, polio, and BCG vaccine (for
tuberculosis)—were to be given to more than 80% of Nigerian children.12 With the
exception of BCG (Table 3), this high level of immunization was never been achieved,
although efforts to immunize children at Primary Health Care centers contributed to
improvements in overall immunization. However, due to political and economic factors,
after 1990, the federal government transferred the administration (and funding) of the
EPI program and primary health care more generally to individual states, after which
immunization levels declined, with levels as low as 30% coverage reported in some
states.13 According to WHO-UNICEF estimates, country-wide immunization for polio
(three doses) stood at 26% in 1996 (Table 3). This was the situation when the Nigerian
government began its participation in the program to eradicate polio worldwide.
The Polio Eradication Initiative
After the successful eradication of smallpox, certified in 1980, international public health
officials considered other diseases that could follow. Because an effective vaccine, protocol
for vaccine delivery and case testing for poliomyelitis had been established, it was decided
that polio should be targeted for eradication. The World Health Assembly voted to
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implement the Polio Eradication Initiative in 1988. Member states were directed to work
to eradicate poliomyelitis with the understanding ‘‘that achievement of the goal will
depend on the political will of countries and on the investment of adequate human and
financial resources.’’14
In Nigeria, this political will has waxed and waned. In July 1995, the Expanded Pro-
gramme on Immunisation was renamed the National Programme on Immunization (NPI)
and in 1996, this program was formally launched by the former First Lady, Miriam Abacha.
The NPI was responsible for conducting the polio initiative although it was affected by
political appointments as well as disinterest on the part of some local politicians and health
officials, factors which impeded the program’s work.15 These political aspects of the cam-
paign may be seen in Kano, the most populous metropolitan center in northern Nigeria,
which was and continues to be the epicenter of continued wild poliovirus transmission.
Much has been written about the former Governor Ibrahim Shekarau’s ban of polio immu-
nization in Kano State in October 2003 due to uncertainty over its safety. However, other
factors affected parents’ willingness to vaccinate their children for polio which was widely
seen as a foreign health intervention.16 In January 2006, the newly appointed acting direc-
tor of the NPI, Dr. Edugie Abebe, sought to address health and safety concerns by imple-
menting a program called Immunization Plus Days (Fig. 2), which provided parents with a
Fig. 2. Immunization Plus Days poster, Nigeria, 2006 (Courtesy of Rotary International, from Smithsonian Institution
website exhibition, ‘‘Whatever Happened to Polio?’’), http://americanhistory.si.edu/polio/poliotoday/immunization.
htm, accessed 18 May 2012.
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range of health incentives, including bed nets, measles vaccination, and deworming
tablets.17
This program was popular and consequently the number of confirmed cases of polio
virus declined from 1,122 cases in 2006 to 285 cases in 2007 (see Table 1). However,
political considerations again intervened and when the National Programme on Immuni-
zation was merged with the National Primary Health Care Development Agency
(NPHCDA), Dr. Abebe resigned. The NPHCDA director who took over the polio
immunization program was inexperienced; funds ran out for bed nets and once again
there was an increase in cases. By the end of November 2008, Nigeria reported 758
confirmed cases, the greatest number of wild poliovirus cases in the world.18
Changes in Nigerian Polio Eradication Efforts
However, several political decisions made at the end of 2008 contributed to a significant
improvement of polio eradication efforts in Nigeria. In October 2008, Dr. Muhammad
Ali Pate, was appointed as the new NPHCDA executive director. Not only was Dr. Pate
an experienced health official who had worked with the World Bank, he was also a
northerner who was sympathetic to the concerns of northern Nigerian parents.19 One
month later, Professor Babatunde Osotimehin was appointed as the Ministry of Health.
Together they worked with members of the Expert Review Panel to revamp the polio
immunization program. While focusing on polio, health officials also incorporated a range
of health incentives along with an emphasis on community communication and improve-
ments in primary health care provision. This change in perspective was reflected in the
Expert Review Committee’s conclusion that ‘‘The growing national and state level com-
mitment to polio eradication and immunization must be taken down to local government
and community level.’’20 The October 2008 report also proposed plans for strengthening
national immunization campaigns in order to maintain polio-free zones in midwestern
and southern states, while improving overall immunization levels in the north, particularly
in the six endemic states—Kano, Zamfara, Katsina, Kaduna, Bauchi, and Jigawa—where
the transmission of wild poliovirus had not been interrupted21
Dr. Pate’s organizational leadership also contributed to increased use of health incen-
tives, as had been successfully employed during Immunization Plus Days (IPDs) begun in
2006. Along with IPDs which tended to focus on high risk areas, the program continued
with National Immunization Days and Sub-National Immunization Days, the latter car-
ried out in endemic areas where they were sometimes extended to continue for several
weeks. These ‘‘Days’’ also incorporated new methods, such as the use ‘‘of ‘transit teams’
to vaccinate children on public and private transport, and the use of ‘street teams’ to
cover children in playgrounds and other areas outside the household.’’22 The massive
immunization efforts in 2009 contributed to significant decline in confirmed cases of wild
poliovirus in Nigeria that year. By the end of October 2009, there were 388 cases, about
half of the 796 cases reported at the same time the previous year. For the year 2010,
there were only 21 cases of wild poliovirus reported for the entire country (see
Table 1).23
Other Factors Contributing to the 2010 Decline
While this steep decline in the number of polio cases reflected greater levels of immunity
among more Nigerian children due to changes in program leadership and improved
immunization campaigns, there were other factors—social, medical, institutional,
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technical, and legal—that contributed to more parents agreeing to have their children
immunized, particularly in northern Nigeria.
In June 2009, Alhaji Muhammad Sa’ad Abubakar, the Sultan of Sokoto, organized a
committee of fourteen northern Nigerian traditional rulers to address the continued pres-
ence of polio in the North.24 While his predecessor, Alhaji Muhammadu Maccido, had
also supported the campaign, the new Sultan’s relative youth and conviction that north-
ern Nigerians should not be seen as ‘‘backward’’ energized his efforts to get traditional
rulers as well as religious leaders involved. His leadership contributed to an increased
acceptance of the polio eradication initiative by many who had rejected it before.
In November ⁄ December 2008, polio vaccines were given in conjunction with a
national integrated measles campaign, with follow-up vaccination days in high risk areas,
which reflected a shift in emphasis, from polio to measles (Fig. 3).25 Since measles was
considered by many northern Nigerian parents as a greater health risk to their children,
this change demonstrated an acknowledgment of local concerns. The increased distribu-
tion of bed nets also reflected an appreciation of parents’ fears about malaria. A more
organized system for bed net distribution was developed in 2010. Mothers who had
brought their children for polio immunization received a slip that entitled them to two
bed nets, which were distributed at local sites by health officials (Figs 4, 5). The popular-
ity of bed nets contributed to increased immunization as well.
In addition to organizing traditional and religious leaders and improving the distribu-
tion of health incentives, state commissioners of education were encouraged to imple-
ment immunization requirements for children attending nursery and primary schools. In
Kaduna State in May 2009, for example, a letter went out to all school principals, noting
that children five years and under needed to participate in immunization exercises when
Fig. 3. Young boy received measles vaccination during supplemental National Immunization Days, Zaria, 1 June
2009 (photograph by E.P. Renne).
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immunization personnel visited their schools (Fig. 6). In one school, 45 out of 50
children were immunized, although some parents objected to this program and wrote
letters requesting that their children not be immunized.26 Nonetheless, the effort to
Fig. 5. Bednet distribution, 29 June 2010, Zaria (photograph by E.P. Renne).
Fig. 4 Bednet slip distributed as part of immunization plus days in June 2010 (photograph by E.P. Renne).
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incorporate immunization records with school attendance is part of a larger process of
routinizing immunization in Nigeria.
Technical improvements in vaccines also increased immunization effectiveness. Wild
poliovirus consists of three different strains, known as type 1, type 2, and type 3. Initially,
the trivalent oral polio vaccine (OPV3) used in the polio eradication initiative included
attenuated strains of all three types. However, after 1999, when the last case of wild
poliovirus type 2 was identified, efforts focused on developing vaccines that were effec-
tive against the remaining two types. Beginning in March 2006, the monovalent oral
polio vaccine effective against the type 1 strain was given to children in Nigeria
(Fig. 7).27 WPV-type 1 was particularly prone to spreading; in 2008, type 1 WPV polio
cases were identified in twenty-three states.28 The monovalent poliovirus vaccine-type 1
more effectively provided immunity so that in 2009, rates of type 1 poliovirus declined
significantly countrywide.
Finally, in January 2009, a US appeals court ruled that parents of children who had
been affected by drug trial of the antibiotic, Trovan (trovafloxacin) could sue the phar-
maceutical corporation, Pfizer, Inc.29 In 1996, an epidemic of cerebrospinal meningitis
occurred in mainly in northern Nigeria, with Kano State being particularly hard hit.30
Pfizer officials sponsored a trial of Trovan at the Infectious Disease Hospital in Kano,
where the oral form of Trovan was given to approximately 100 children; another 100
Fig. 6. Notice to school principals about immunization, 13 May 2009 (photograph by E.P. Renne).
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children were given the antibiotic, Cephtriaxone, the standard treatment for cerebrospinal
meningitis as a control. Of the children involved in the study, eleven subsequently died–
five who had been given Trovan, six whom were given Cephtriaxone. Subsequently, a
lawsuit was filed by families of the affected children in a US District Court in New York
in 2002, which was initially dismissed. After several delays and adjournments, the earlier
2002 US District Court ruling was overturned and in July 2009, an out-of-court settle-
ment for $75 million was signed.31 Yet the consequences of this failed drug trial, locally
referred to as ‘‘Pfizer,’’ have not been forgotten in Kano, as the Kano State Commis-
sioner for Health, Hajiya Aisha Isyaku Kiru, observed:
[She] attributed the low patronage of immunisation in the state to the drug trial carried out by
Pfizer Pharmaceutical Company which was confirmed to have adverse effect on children.
‘‘Although the trial occurred years ago, it has served as deterrent to the people of the state who
are still making reference to it whenever the issue of immunization comes up.’’32
The legal settlement did not reverse the damage done by the drug trial, either for the
parents of children who subsequently died or were severely disabled, or for the credibility
of later Western health interventions. However the settlement of the case against Pfizer,
which was widely reported in the northern Nigerian press, did show that Western phar-
maceutical companies could be punished for their actions in Nigeria.
A Few Remaining Cases, Some Continuing Problems
The innovations in the polio eradication initiative that brought case numbers down in
2010 have continued in 2011 although there have also been setbacks in program imple-
mentation. For example, during the federal and state elections, there were ‘‘stock outs,’’
with no vaccine availability in some health centers.33 Post-election violence, particularly
Fig. 7. Rate of poliomyelitis attributed to wild poliovirus type 1, by state, in 2006, before and after mOPV1 was
given (Centers for Disease Control and Prevention, Morbidity and Mortality Weekly Report 56 ⁄ 12 (2007): 281).
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in Kaduna State but in other northern Nigerian states as well, has also affected immuniza-
tion efforts. Furthermore, difficulties in maintaining a supply of health incentives such as
bed nets discouraged some parents from participating. Thus, low levels of polio immuni-
zation have persisted in some areas, along with a slight increase in confirmed cases of wild
poliovirus in 2011. Two states in particular continue to present problems for polio eradi-
cation efforts in Nigeria—Kano and Borno, although transmission continues in other
northern Nigerian states (Fig. 8).
Political insecurity, along with continued economic hardship, intermittent efforts at
implementing earlier national health policies, and continued distrust of government
programs, have hampered efforts to stop polio transmission in 2011. Yet the number of
confirmed cases of wild poliovirus (62) and circulating vaccine-derived poliovirus (33)
remain low, with a total of 95 cases by 31 December 2011 (Table 1). Members of the
Expert Review Committee as well as Dr. Pate are promoting measles and polio immuni-
zation days as well as the improvement of national routine immunization efforts and
primary health care (PHC), which Pate has referred to as ‘‘the bedrock of Nigeria’s health
system.34
This policy reflects the fact that even when polio transmission has been stopped, it will
still be necessary to maintain high levels of immunization against polio as well as against
other childhood diseases. Health officials see improvements in routine immunization as
an important part in ending polio transmission in Nigeria.
Conclusion
Earlier inattention to polio in Nigeria was followed by the polio eradication initiative,
which initially focused solely on polio during a time when the primary health care system
was in decline. No other diseases were included in the campaign (as had been the case
Fig. 8. Map of Nigeria showing Local Government Areas (LGAs) with polio ⁄ polio risk ⁄ immunization levels (Courtesy
of UNICEF, <http://www.polioinfo.com> website).
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during the smallpox eradication program) nor were local communities consulted about
the sort of health interventions they preferred. In 2006, with the subsequent reorganiza-
tion of the program, which included consultation with local leaders, the inclusion of
health incentives through Immunization Plus Days,35 and better monitoring (Fig. 9), the
number of polio cases significantly declined. Political problems within the program inter-
rupted this decline in 2008, but with new leadership installed in October 2008, along
with the other factors discussed above, Nigeria was able to report less than 50 cases (of
both wild and vaccine-derived) poliovirus in 2010. While these changes still represented
an override approach in the sense that polio was the underlying focus, it nonetheless
reflected a shift toward more collaborative perspective whereby local concerns about
malaria and measles were also being taken into account. The increasing emphasis on col-
laborative efforts as well as routine immunization and improvements in village primary
health care offer new hope for ending polio transmission in Nigeria.36
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